Schleimer R P, Lane Andrew P, Kim J
Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Clin Allergy Immunol. 2007;20:51-78.
We have outlined the myriad of roles, both proven and suspected, of epithelial cells in airway inflammation in general and CRS in particular. There is little doubt that these remarkable cells are essential for host defense, tissue responses to injury and threats, and inflammation that cause disease. We believe that many of these responses are likely to be amenable to the development of new therapies for CRS. As we acquire more information on the signaling processes that drive the protective responses in epithelial cells, we will improve our chances of developing approaches to enhance these responses without triggering deleterious inflammatory responses. Enhanced clearance of fungi and bacteria by local immune responses would likely be beneficial in reducing disease. As we better understand the signals that epithelial cells give and get from DCs, B and T lymphocytes, new opportunities for productive intervention will arise.
我们已经概述了上皮细胞在一般气道炎症尤其是慢性鼻-鼻窦炎(CRS)中所扮演的众多角色,既有已证实的,也有疑似的。毫无疑问,这些非凡的细胞对于宿主防御、组织对损伤和威胁的反应以及导致疾病的炎症至关重要。我们相信,其中许多反应可能适合开发针对CRS的新疗法。随着我们获得更多关于驱动上皮细胞保护性反应的信号传导过程的信息,我们将提高开发增强这些反应而不引发有害炎症反应方法的机会。通过局部免疫反应增强真菌和细菌的清除可能有助于减少疾病。随着我们更好地理解上皮细胞与树突状细胞、B淋巴细胞和T淋巴细胞之间传递和接收的信号,将出现富有成效的干预新机会。